Home / Research peptides / Tirzepatide — 10mg

NXT LVL · Laboratory series
Tirzepatide — 10mg
10mg per vial · Lyophilized Powder
Choose 1–10 vials and compare quantity discounts. Review batch reports and ordering requirements before purchasing.
In stock · Ready to ship. Dispatch in 1–2 business days after acceptance and payment; transit is additional. Review lot documentation before ordering.
$139.00 per vial
Select quantityPack pricing · USD
Select quantity.
Shipping & payment information
- U.S. shippingStandard $12.00 · overnight $30.00. Dispatch in 1–2 business days after acceptance and payment; transit is additional. Confirm overnight availability first.
- South Florida deliveryLocal delivery is $25.00 after address and availability confirmation. Check delivery availability ↗
- Free standard shipping over $200After discounts. Exactly $200 pays $12 standard shipping. Overnight and local delivery are free above $475; exactly $475 pays their listed fees.
- Payment at checkoutReview current payment options and the final order total in checkout. Read the payment guide and final-sale policy before payment.
Material documentation
Request the report for your lot
A matching report for Tirzepatide — 10mg is not currently linked in the public report library. Request the identity, analytical results and documentation for the specific lot before ordering.
Match material identity, labeled amount and lot details. A reference paper or a report for another sample does not certify this stock.
Material reference
Tirzepatide research overview
Tirzepatide was described in discovery research under the identifier LY3298176 as a dual GIP and GLP-1 receptor agonist. Receptor identity and molecular characterization are useful when distinguishing it from other incretin-related research compounds. A shared 10mg vial label does not establish equivalent materials.
Reference sources
- Coskun et al. (2018): characterization of LY3298176 / tirzepatide ↗
- Li et al. (2024): retatrutide structures at GLP-1, GIP and glucagon receptors ↗
Sources describe reference chemistry or published experiments. They do not establish identity, purity, suitability or effects for NXT LVL stock. No human-use instructions are provided.
What to verify for this material
- Match the molecular identity and any specified modifications to tirzepatide / LY3298176 in the offered lot documentation.
- Review measured amount, chromatographic result and identity evidence as separate items; none can be established solely from the product title.
Is tirzepatide interchangeable with retatrutide in a material specification?
No. They are distinct reference compounds. The cited studies characterize tirzepatide at GIP and GLP-1 receptors and retatrutide at those receptors plus the glucagon receptor. Select and document the exact material required by your laboratory.
Compare catalog listings
These links help distinguish materials and presentations; they are not combination recommendations.
Reference notes prepared by NXT LVL Research · Sources checked November 2, 2026. How to review analytical evidence ↗
Material & purchase details
- Catalog reference
- tirzepatide
- Labeled amount
- 10mg per vial
- Supplied format
- Lyophilized Powder
- Single-vial price
- $139.00 USD
- Quantity options
- 1–10 vials; select a pack for quantity savings
- Documentation
- Request the report for the offered lot
Labeled amounts describe the supplied material, not a dose. Compare vial count, total pack price and the report for each lot. Read the research purchasing guide ↗
For laboratory research use only. Not for human consumption, medical, veterinary, or diagnostic use.